The Valley Desk

NCT02573324 · Interventional trial

A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

Overall registry status Completed

Phase 3

Conditions Glioblastoma, Gliosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov